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Abstract
Antenatal register data from 62 clinics in 5 regions of Kenya were used to estimate women with 
human immunodeficiency virus (HIV) risk (partner HIV status, syphilis). With individual risk-
guided preexposure prophylaxis (PrEP) offer in all regions, 39% of pregnant women would be 
offered PrEP nationally. Offering PrEP to all women in high-prevalence regions reached 26% of 
the pregnant women.
To reach elimination of mother-to-child transmission (EMTCT) of human 
immunodeficiency virus (HIV) targets, the World Health Organization (WHO) recommends 
offering preexposure prophylaxis (PrEP) to HIV-negative pregnant women in HIV high-
burden settings.1,2 The WHO also recommends using risk-guided approaches where HIV 
risk assessment tools are used during routine antenatal care (ANC) visits to identify HIV-
uninfected pregnant women who would benefit most PrEP.1 Alternatively, PrEP could be 
offered to all HIV-uninfected women in ANC in subnational regions with high HIV burden 
where HIV incidence is likely highest. Programmatic delivery of PrEP for pregnant women 
is being considered in sub-Saharan African settings,3 and there is a critical need for research 
on how best to operationalize PrEP delivery within ANC.4
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Setting national and subnational PrEP targets could help decision makers and health 
planners in forecasting drug procurement and assessing the budgetary allocation for PrEP 
implementation for ANC clients. Targets also help motivate programs to reach pregnant and 
postpartum women who may benefit from PrEP services most. Countries planning to offer 
PrEP to pregnant women could use available epidemiologic data from surveys or ANC 
programs to make pragmatic initial targets which can be adjusted when demand is better 
understood after implementation.
Previous studies among pregnant women in Kenya have found HIV incidence rates between 
3.4 to 6.8 per 100 person-years5,6 Kenya national guidelines recommend PrEP for 
individuals with high risk of HIV acquisition, including pregnant women,3 though large-
scale implementation through ANC has not been rolled out. To inform scale-up of PrEP 
delivery for pregnant women in Kenya, we estimated the number and proportion of HIV-
uninfected pregnant women in Kenya who could be offered PrEP under different pragmatic 
approaches, including offering PrEP based on regional HIV prevalence and/or individual-
level HIV risk factors at the national level.
METHODS
Design
We conducted a secondary analysis using data from a large cross-sectional survey of 
standardized Ministry of Health ANC registers.7 The primary aim of the parent study was to 
evaluate programmatic PMTCT indicators, including maternal HIV testing in ANC. 
Facilities providing routine ANC services with 100 or greater annual HIV-infected ANC 
clients (as reported to the Kenya National AIDS and STI Control Program) were randomly 
selected for inclusion, using stratified random sampling (stratified by facility size). The 
number of facilities selected in each strata was proportional to the number of facilities within 
each strata; 62 facilities were selected from the 92 facilities in the overall sampling frame. 
Selected facilities were from the regions of Nyanza, Nairobi, Coast, Rift Valley, and Eastern. 
Data from the first 10% of all first ANC visits were included for each year from 2011 to 
2013. Ethical approval was obtained from the ethical review committees at the Kenya 
Medical Research Institute, the University of Washington, and the US Centers for Disease 
Control and Prevention.
Data Abstraction
The ANC registers contained information on demographics, obstetric history, maternal and 
partner HIV status, and other routine maternal health indicators. Study staff scanned each 
ANC register page with identifying information blocked with an opaque cover. Data were 
digitized using Captricity, a proprietary cloud-based data transcription service that uses a 
combination of computer algorithms and manual checks to digitize handwritten data. Image 
capture and digitization were piloted before study implementation to ensure consistency 
between paper-based and digitized data. Data accuracy was verified daily during study 
implementation.
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Definition of Variables
We defined high HIV risk based on individual-level characteristics as having syphilis 
(documentation rapid plasma reagin–positive results) and/or having a partner of unknown or 
positive HIV status. These characteristics were selected based on the availability of 
indicators in the registries, previous studies which identified these characteristics as risk 
factors in an empiric risk score for HIV acquisition among pregnant women in Kenya,8 and 
current Kenya National AIDS and STI Control Program guidelines3 which recommend PrEP 
for individuals who recently had an sexually transmitted infection (STI) and/or have sex 
partners of positive or unknown HIV status.
Statistical Analyses
We estimated the absolute number and proportion of HIV-uninfected pregnant women in 
Kenya who could be offered PrEP under three different public health approaches, including 
offering PrEP to: (1) all HIV-uninfected pregnant women nationally with high HIV risk 
based on our defined individual-level characteristics; (2) all HIV-uninfected pregnant 
women, regardless of individual-level risk, only in the region with highest HIV prevalence; 
and (3) all HIV-uninfected pregnant women, regardless of individual-level risk, only in the 
region with highest HIV prevalence and all HIV-uninfected pregnant women nationally with 
individual-level high HIV risk.
We multiplied the total number of pregnant women nationally according to Kenya 
Demographic and Health Survey 2014 (1.53 million) by the proportion of women in Eastern, 
Coast, Rift Valley, Nairobi and Nyanza regions (74%) to estimate the number of pregnant 
women for all regions that contributed data to our study.9 The number of pregnant women 
with high HIV risk based on individual-level characteristics was estimated by multiplying 
the total number of pregnant women by the proportion with syphilis and/or a partner of 
unknown or positive HIV status. The number of pregnant women in Nyanza (the region with 
the highest HIV prevalence based on the Kenya AIDS Indicator Survey 2012) was estimated 
by multiplying the total number of pregnant women nationwide (1.53 million) by the 
proportion in Nyanza (26%). All analyses were weighted to account for the complex 
sampling design, including clustering at the clinic level.
RESULTS
Overall, 8634 ANC attendees (93% of all abstracted records) were HIV-uninfected and had 
data on syphilis or partner HIV status. The regional distribution of ANC attendees was as 
follows: Eastern, 1127 (13.1%); Rift Valley, 1284 (14.9%); Coast, 1396 (16.2%); Nairobi, 
1619 (18.8%); and Nyanza, 3208 (37.2%). The median age of ANC attendees was 24 years, 
18% were younger than 20 years, most were married (86%), and 37% were primigravidas.
Syphilis testing results were available for 69% of ANC attendees and among those with 
results, 1% were rapid plasma reagin–positive. Data on male partner HIV status were 
available for 85% of ANC attendees of which nearly half (54%) had documentation of 
unknown male partner HIV status. Only 3% had HIV tested as a couple and 1% reported 
knowing their male partner was HIV-infected. Among all regions, 39% of women had either 
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documentation of syphilis infection and/or a partner of positive or unknown HIV status, 
which defined high HIV risk based on individual-level characteristics in our study; 34% of 
all women with high risk for HIV resided in Nyanza. Regions with 30% or greater of 
individuals having high HIV risk based on individual-level characteristics overlapped with 
higher HIV prevalence regions (Fig. 1A). Prevalence of high HIV risk was highest in 
Nyanza (51%), significantly higher than other regions (prevalence ratio, 1.5, 95% confidence 
interval, 1.1–2.2; P = 0.04). In all other regions, less than 40% of women had high HIV risk 
(Fig. 1A).
Offering PrEP to all HIV-uninfected pregnant women regardless of individual-level risk in 
Nyanza would result in an estimated 295,005 women offered PrEP (Fig. 1B). By offering 
PrEP nationwide to women with high HIV risk in all regions based on individual-level 
characteristics, 447,046 pregnant women would be offered PrEP; offering PrEP additionally 
to all women in Nyanza would result in 145,143 more pregnant women being offered PrEP 
(592,189 women overall). We repeated the analyses to estimate the proportion of pregnant 
women nationally covered in each of the approaches for offering PrEP (Fig. 1B). Offering 
PrEP to all women in Nyanza in addition to all women in other regions with high HIV risk 
based on individual-level characteristics would raise coverage of offering PrEP to 52% of all 
pregnant women in Kenya.
DISCUSSION
Our study is the first to estimate the number of HIV-uninfected pregnant women who could 
be offered PrEP in a high HIV prevalence country under pragmatic scenarios. In this large 
survey, frequency of high HIV risk was common based on routinely collected ANC 
indicators. We found that an approach for offering PrEP that incorporates individual-level 
HIV risk and regional HIV prevalence would result in PrEP offer to 52% of pregnant women 
in Kenya. Restricting PrEP offer to all women in high prevalence region would involve 26% 
of all pregnant women in Kenya, whereas offer to women with individual risk factors in all 
regions would result in offering 39% of women PrEP. Understanding regional differential 
HIV incidence during pregnancy will be important to refine programmatic decisions. Our 
findings could inform the development of conceptual models for PrEP delivery in pregnancy 
and parameterization of more comprehensive mathematical models of different PrEP 
delivery approaches.
Less than 5% of ANC attendees in our study tested for HIV with their partners, and over half 
did not know their partner’s HIV status. Accurate partner HIV status information is key to 
preventing new HIV infections in pregnant women and to targeting effective prevention 
strategies.10,11 Promoting male partner HIV testing, including with HIV self-test kits, may 
reduce the number of pregnant women who initiate PrEP.12,13 Syphilis is associated with 
increased incidence of HIV among pregnant women and routinely screened for within ANC.
5,14
 Nearly one third of ANC attendees were missing syphilis results in our study, 
highlighting the need for continued dual EMTCT of HIV and syphilis efforts. In our study, 
high HIV risk based on individual-level characteristics varied from 28% to 51% across 
regions. Future mathematical models that evaluate national or regional prioritization of PrEP 
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for pregnant women are needed to understand the cost-effectiveness of PrEP in this 
population.
Our study has limitations. We only selected facilities with 100 or more annual HIV-infected 
ANC clients and therefore our results may over represent areas with higher community-level 
HIV risk. We abstracted data from registries that were initially completed for nonresearch 
purposes. Thus, an appreciable proportion of entries had missing data. Important markers of 
HIV risk, such as intimate partner violence and nonsyphilis STIs are not captured in ANC 
registers. Frequency of true HIV serodiscordance is likely higher than what was self-
reported as few women tested as a couple. Our analysis does not include mathematical 
modeling or cost-effectiveness analyses. Additionally, we focus on estimations for offering 
PrEP without incorporating data on uptake. Women with low HIV risk may not consider 
taking PrEP. Forecasting programmatic needs in the future should include uptake of PrEP 
among pregnant women.
In conclusion, data from ANC registers may be useful for estimating numbers and regional 
distribution of women at risk for HIV who would benefit from PrEP in ANC/PNC settings.
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Figure 1. 
A, Frequency of potential high HIV risk based on individual-level risk factor among 
pregnant women and adult HIV prevalence (Kenya AIDS Indicator Survey 2012)19, by 
regoin.1,2 B, Estimated PrEP coverage using risk-based versus regional prevalence 
approaches for offering PrEP to pregnant women in Kenya.
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